111
Views
9
CrossRef citations to date
0
Altmetric
Research Article

PECAM-1, Apoptosis and CD34+ Precursors

&
Pages 2205-2213 | Published online: 01 Jul 2009

References

  • Hengartner, M.O. (2000) "The biochemistry of apoptosis", Nature, 407, 770–776.
  • Frisch, S.M. and Ruoslahti, E. (1997) "Integrins and anoikis", Curr. Opin. Cell. Biol., 9, 701 —706.
  • Ashkenazi, A. and Dixit, V.M. (1998) "Death receptors: signalling and modulation", Science, 281, 1305–1308.
  • Zamzami, N. and Kroemer, G. (2001) "The mitochondrion in apoptosis: how Pandora's box opens", Nat. Rev. MoL Cell. Biol., 2, 67–71.
  • Chao, D.T. and Korsmeyer, S.J. (1998) "Bc1-2 family: regulators of cell death", Annu. Rev. Immunol., 16, 395–419.
  • Cheng, E.H., Wie, M.C., Weiler, S., Flavell, R.A., Mak, T.W., Lindsten, T., et al. (2001) "BCL-2, BCL-XL sequester BH3 domain-only molecules preventing Bax- and Bak-mediated mitochondrial apoptosis", Mol. Cell, 8, 705–711.
  • Hsu, Y.T., Wolter, K.G. and Joule, R.J. (1997) "Cytosol-to-membrane redistribution of Bax and Bc1-X(L) during apoptosis", Proc. Natl. Acad. Sci. USA, 94, 3668–3672.
  • Antonsson, B., Montessuit, S., Sanchez, B. and Martinou, J.C. (2001) "Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells", J. Biol. Chem., 276, 11615–11623.
  • Rodriguez, J. and Lazebnik, Y. (1999) "Caspase-9 and APAF-1 for an active holoenzyme", Genes Dev., 13, 3179–3184.
  • Deveraux, Q.L. and Reed, J.C. (1999) "IAP family proteins-suppressors of apoptosis", Genes Dev., 13, 239–252.
  • Ardeshna, KM., Pizzey, AR., Devereux, S. and Khwaja, A. (2000) "The PI3 kinase, p38 SAP kinase, and NF-kB signal transduction pathways are involved in the survival and maturation of lipopoly-saccharide-stimulated human monocyte-derived dendritic cells", Blood, 96, 1039 — 1046.
  • Chan, TO., Rittenhouse, S.E. and Tsichlis, P.N. (1999) "AKT/PKB and other D3phosphoinositide-regulated kinases: kinase activation-by phosphoinositide-dependent phosphorylation", Annu. Rev. Biochem., 6, 965 — 1014.
  • Pugazhenti, S., Nesterova, A., Sable, C., Heidenreich, K.A., Boxer, L.M., Heasley, L.E., et al. (2000) "Akt/Protein kinase B up-regulates Bc1-2 expression through cAMP-response element-binding protein", J. Biol. Chem., 275, 10761 — 10766.
  • Zhou, H., Li, X.M., Meinkoth, J. and Pittman, RN. (2000) "Akt regulates cell survival and apoptosis at a postmitochondrial level", J. Cell. Biol., 151, 483–494.
  • Wang, J.F., Park, I.W. and Groopman, J.E. (2000) "Stromal cell-derived factor-1 alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hemato-poietic progenitor cells: roles of phopshoinositide-3 kinase and protein kinase C", Blood, 95, 2505–2513.
  • Maika, M., Janowska-Wiekzorek, A., Ratajczak, J., Ehrenman, K., Pietrzkowski, Z., Kowalska, M.A., et al. (2001) "Numerous growth factors, cytokines and chemokines are secreted by human CD34 ± cells, myeloblasts, erythroblasts and megacarioblasts and regulate normal hemopoiesis in an autocrine/paracrine manner", Blood, 97, 3075–3085.
  • Zeuner, A., Pedini, F., Signore, M., Testa, U., Pelosi, E., Peschle, C., et al. (2003) "Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins", Blood, 102, 87–93.
  • Lemoli, R.M., Tafuri, A., Fortuna, A., Petrucci, MT., Ricciardi, M.R., Catani, L., et al. (1997) "Cycling status of CD34 ± cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor", Blood, 89, 1189 — 1196.
  • Aiuti, A., Webb, I.J., Bleul, C., Springer, TA. and Gutierrez-Ramos, J.C. (1997) "The chemokine SDF-1 is a chemoattractant for human CD34 ± hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34 ± progenitors to peripheral blood", J. Exp. Med., 185, 1 1 1 —120.
  • Kim, C.H. and Broxmeyer, HE. (1998) "In vitro behaviour of hematopoietic progenitor cells under the influence of chemoattrac-tants: stromal cell-derived factor-1, steel factor, and the bone marrow environment", Blood, 91, 100 —110.
  • Imhof, BA. and Dunon, D. (1995) "Leukocyte migration and adhesion", Adv. ImmunoL, 58, 345 —416.
  • Kinashi, T. and Springer, TA. (1994) "Adhesion molecules in hemopoietic cells", Blood Cells, 20, 25–44.
  • Schweitzer, C.M., Drager, A.M., van der Walk, P., Thijsen, S.F.T., Zevenbergen, A., Theijmeijer, A.P., et al. (1996) "Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hemopoietic tissues", Am. J. Pathol.,148, 165 — 175.
  • Yong, K., Watts, M., Thomas, N.S., Sullivan, A., Ings, S. and Linch, D. (1998) "Transmigration of CD34 ± cells across specia-lized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31)", Blood, 91, 1196 — 1205.
  • Watt, S.M., Williamson, J., Genevier, H., Fawcett, J., Simmons, D.L., Hatzfeld, A., et al. (1993) "The heparin binding PECAM-1 adhesion molecule is expressed by CD34 ± hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes", Blood, 82, 2649–2663.
  • Williams, D.A., Rios, M., Stephens, C. and Patel, V.P. (1991) "Fibronectin and VLA-4 in haematopoietic stem cell-microenviron-ment interactions", Nature, 352, 438–441.
  • Miyake, K., Medina, K.L., Hayshi, S.-Y., Ono, S., Hamaoka, T. and Kincade, T.W. (1990) "Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures", J. Exp. Med., 17, 477–488.
  • Bruno, E., Luikart, S.D., Long, M.F. and Hoffman, R. (1995) "Marrow-derived heparan sulphate proteoglycan mediates the adhesion of hemopoietic progenitor cells to cytokines", Exp. Hematol., 23, 1212–1217.
  • Stossel, T.P. (1994) "The machinery of cell movement", Blood, 84, 367–379.
  • Lawson, M.A. and Maxfield, F.R. (1995) "Ca2 ± and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils", Nature, 377, 75–79.
  • Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. and Springer, T.A. (1996) "A highly efficacious lymphocyte chemoat-tractant, stromal cell-derived factor-1 (SDF-1)", J. Exp. Med., 184, 1101 —1109.
  • Deichman, M., Kronenwett, R. and Haas, R. (1997) "Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34 ± hematopoietic progenitor cells", Blood, 89, 3522— 3528.
  • Zhou, Y.-R., Kottmann, A.H., Kudora, M., Taniuchi, I. and Littman, D.R. (1998) "Function of the chemokine receptor CXCR-4 in hematopoiesis and in cerebellar development", Nature, 393, 595— 599.
  • Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., et al. (1999) "Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR-4", Science, 283, 845 — 848.
  • Voersman, C., Kooi, M.L.K., Rodenhuis, S., van der Lelie, H., van der Schoot, E. and Gerritsen, W.R. (2001) "In vitro migratory capacity of CD34 ± cells is related to hematopoietic recovery after autologous stem cells transplantation", Blood, 97, 799–804.
  • Williams, A.F. and Barclay, A.N. (1988) "The immunoglobulin superfamily. Domains for cell surface recognition", Annu. Rev. Immunol., 6, 381–405.
  • Kirschbaum, N.E., Gumina, R.J. and Newman, P.J. (1994) "Organization of the gene for human platelet endothelial cell adhesion moilecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain", Blood, 84, 4828–4837.
  • Muller, W.A., Weigl, S.A., Deng, X. and Phillips, D.M. (1993) "PECAM-1 is required for transendothelial migration of leuko-cytes", J. Exp. Med., 178, 449–460.
  • Newman, P.J. (1997) "The biology of PECAM-1", J. Clin. Invest., 99, 3–8.
  • Liao, F., Huynh, H.K., Eiroa, A., Greene, T., Polizzi, E. and Muller, W.A. (1995) "Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1", J. Exp. Med., 182, 1337–1342.
  • Piali, L., Hammel, P., Uherek, C., Bachmann, F., Gisler, R.H., Dunon, D., et al. (1995) "CD31/PECAM-1 is a a ligand for av,63 integrin involved in adhesion of leukocytes to endothelium", J. Cell. Biol., 130, 451 — 460.
  • Zehnder, J.L., Shatsky, M., Leung, L.L.K., Butcher, E.C., McGregor, J.L. and Levitt, L. (1995) "Involvement of CD31 in lymphocyte-mediated immune responses: importance of the mem-brene-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide", Blood, 85, 1282–1288.
  • Wong, C.W., Wiedle, G., Ballestrem, C., Wehrle-Haller, B., Etteldorf, S., Bruckner, M., et al. (2000) "PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of ist cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis", Mol. Biol. Cell., 11, 3109 — 3121.
  • Poggi, A., Panzeri, M.C., Moretta, L. and Zocchi, M.R. (1996) "CD31-triggered rearrangement of the actin cytoskeleton in human natural killer cells", Eur. J. Immunol., 26, 817–824.
  • Fawcett, J., Buckley, C., Holness, C.L., Bird, IN., Spragg, J.H., Saunders, J., et al. (1995) "Mapping of the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts", J. Cell. Biol., 128, 1229–1241.
  • Sun, Q.-H., DeLisser, H.M., Zukowski, M.M., Paddock, C., Albelda, S.M. and Newman, P.J. (1996) "Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor activity", J. Biol. Chem., 271, 11090–11098.
  • Tanaka, Y., Albelda, S.M., Horgan, KJ., van Seventer, G.A., Shimizu, Y., Newman, W., et al. (1992) "CD31 expressed on distinctive T cell subsets is a preferential amplifier of /31 integrin-mediated adhesion", J. Exp. Med., 176, 245–253.
  • Zehnder, J.L., Hirai, K., Shatsky, M., McGregor, J.L., Levitt, L.J. and Leung, L.L.K. (1992) "The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 after T cell activation", J. Biol. Chem., 287, 5243 — 5249.
  • Ferrero, E., Villa, A., Ferrero, M.E., Toninelli, E., Bender, J.F., Pardi, R., et al. (1996) "Tumor necrosis factor alpha-induced vascular leakage involves PECAM1 phosphorylation", Cancer Res., 56, 3211–3215.
  • Zocchi, M.R., Ferrero, E., Leone, B.E., Rovere, P., Bianchi, E., Toninelli, E., et al. (1996) "CD31/PECAM-1-driven chemokine-independent transmigration of human T lymphocytes", Eur. J. Immunol., 26, 759–767.
  • DeLisser, H.M., Chilkotowski, J., Yan, H.C., Daise, ML., Buck, C.A. and Albelda, S.M. (1994) "Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) results in changes in ligand binding properties", J. Cell. Biol., 124, 195–203.
  • Sun, J., Williams, J., Yan, H.C., Amin, K.M., Albelda, S.M. and DeLisser, H.M. (1996) "Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobu-lin-like domains 1 and 2 and depends on the cytoplasmic domain and on the level of surface expression", J. Biol. Chem., 271, 18561 — 18570.
  • Newman, P.J. (1999) "Switched at birth: a new family for PECAM-1", J. Clin. Invest., 103, 5–9.
  • Wilkinson, R., Lyons, A.B., Roberts, D., Wong, M.-X., Bartley, P.A. and Jackson, D.E. (2002) "Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell devel-opment, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease", Blood, 100, 184–193.
  • Newman, D.K., Hamilton, C. and Newman, P.J. (2001) "Inhibition of antigen receptor signalling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP2, and p561ck", Blood, 97, 2351–2357.
  • Goldberger, A., Middleton, K.A., Oliver, JA., Paddock, C., Yan, H.-C., DeLisser, H.M., et al. (1994) "Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form", J. Biol. Chem., 269, 17183–17191.
  • Sagawa, K., Kimura, T., Swieter, M. and Siraganian, R.P. (1997) "The proteintyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31)", J. Biol. Chem., 272, 31086–31091.
  • Jackson, D.E., Ward, CM., Wang, R. and Newman, P.J. (1996) "The protein-tyrosine phosphatase SHP2 binds to platelet/endothe-lial cell adhesion molecule-1 (PECAM-1) and forms a distinct signalling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1 and integrin-mediated cellular signalling", J. Biol. Chem., 272, 6986–6993.
  • Hua, CT., Gamble, J.R., Vadas, M.A. and Jackson, D.E. (1998) "Recruitment and activation of SHP-1 protein-tyrosine phospha-tase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates", J. Biol. Chem., 273, 28332–28340.
  • Hof, P., Pluskey, S., Dhe-Paganon, S. and Shoelson, S.E. (1998) "Crystal structure of the tyrosine phosphatase SHP-2", Cell, 92, 441 — 450.
  • Isakov, N. (1997) "ITIMs and ITAMs. The Yin and Yang of antigen and Fe receptor-linked signalling machinery", Immunol. Res., 16, 85— 100.
  • Henshall, T.L., Jones, K.L., Wilkinson, R. and Jackson, D.E. (2001) "Src homology 2 domain-containing protein-tyrosine phosphatases, shp-1 and shp-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signalling", J. Immunol., 166, 3098 — 3106.
  • Cao, MY., Huber, M., Beauchemin, N., Famiglietti, J., Albelda, S.M. and Veillette, A. (1998) "Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases", J. Biol. Chem., 273, 15765–15772.
  • Ilan, N., Cheung, L., Pinter, E. and Madri, J.A. (2000) "Platelet endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation", J. Biol. Chem., 14, 21435–21443.
  • Noble, K.E., Wickremasinghe, R.G., DeComet, C., Panayiotidis, P. and Yong, K.L. (1999) "Monocytes stimulate expression of the Bcl-2 family member, Al, in endothelial cells and confers protection from apoptosis", J. Immunol., 162, 1376— 1383.
  • Bird, IN., Taylor, V., Newton, J.P., Spragg, J.H., Simmons, DL., Salmon, M., et al. (1999) "Homophilic PECAM-1(CD31) interac-tions prevent endothelial cell apoptosis but do not support cell spreading or migration", J. Cell Sci., 112, 1989 — 1997.
  • Ferrero, E., Belloni, D., Contini, P., Foglieni, C., Ferrero, ME., Fabbri, M., et al. (2003) "Transendothelial migration leads to protection from starvation-induced apoptosis in CD34 + CD14 + circulating precursors: evidence for PECAM-1 involvement through Akt/PKB activation", Blood, 101, 186 — 193.
  • Pellegatta, F., Chierchia, S.L. and Zocchi, M.R. (1998) "Functional association of platelet endothelial cell adhesion molecule-1 and phosphoinositide-3 kinase in human neutrophils", J. Biol. Chem., 273, 27768 — 27771.
  • Gao, C., Sun, W., Christofidou-Solomidou, M., Sawada, M., Newman, D.K., Bergom, C., et al. (2003) "PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apopto-sis", Blood, 102, 169 — 179.
  • Pumphrey, N.J., Taylor, V., Freeman, S., Douglas, MR., Bradfield, P.F., Young, S.P., et al. (1999) "Differential association of cytoplasmic signalling molecules SHP-1, SHP-2 and SHIP and phospholipase C-gamma 1 with PECAM-1/CD31", FEBS Lett., 450, 77–83.
  • Lu, T.T., Barreuther, M., Davis, S. and Madri, J.A. (1997) "Platelet endothelial cell adhesion molecule-1 is phosphorylatable by c-Src, binds Src-Src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation motif-like properties", J. Biol. Chem., 272, 14442–14446.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.